M. Lommatzsch, S. Korn, O. Schmidt, H. Timmermann, H. Watz, A. Radwan, Lucia De Prado-Gomez, A. Atenhan, S. Barbus, M. Thakur
{"title":"摘要:在一项跨国非介入性研究(ProVENT)中,在常规临床实践中接受Dupilumab治疗的患者的真实世界特征","authors":"M. Lommatzsch, S. Korn, O. Schmidt, H. Timmermann, H. Watz, A. Radwan, Lucia De Prado-Gomez, A. Atenhan, S. Barbus, M. Thakur","doi":"10.1183/13993003.congress-2021.pa564","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)\",\"authors\":\"M. Lommatzsch, S. Korn, O. Schmidt, H. Timmermann, H. Watz, A. Radwan, Lucia De Prado-Gomez, A. Atenhan, S. Barbus, M. Thakur\",\"doi\":\"10.1183/13993003.congress-2021.pa564\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7848,\"journal\":{\"name\":\"Airway Pharmacology and Treatment\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Airway Pharmacology and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2021.pa564\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Airway Pharmacology and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2021.pa564","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)